DJIA 17,928.20 -142.20 -0.79%
NASDAQ 4,939.33 -77.60 -1.55%
S&P 500 2,089.46 -25.03 -1.18%
market minute promo

GlaxoSmithKline (NYSE: GSK)

45.60 -0.74 (-1.60%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GSK $45.60 -1.60%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $46.36
Previous Close $46.34
Daily Range $45.56 - $46.44
52-Week Range $41.25 - $55.63
Market Cap $122.1B
P/E Ratio 15.92
Dividend (Yield) $2.78 (5.6%)
Ex-Dividend Date
Dividend Pay Date
02/18/15
04/09/15
Volume 3,486,811
Average Daily Volume 3,216,906
Current FY EPS $2.73

Sector

Healthcare

Industry

Drug Makers

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary

Why Agenus Inc. Shares Surged Higher In Early Trading Today

Agenus Inc. shares jumped sharply on positive data for a shingles vaccine that uses its QS-21 Stimulon.

Bert's April Dividend Income

LyondellBasell, Container Store, GlaxoSmithKline, Novartis and Genocea Biosciences highlighted as Za

LyondellBasell, Container Store, GlaxoSmithKline, Novartis and Genocea Biosciences highlighted as Zacks Bull and Bear of the Day - Press Releases

Why Earnings Season Could Be Great for GlaxoSmithKline (GSK) - Tale of the Tape

Will Glaxo (GSK) Beat Earnings Estimates This Season? - Analyst Blog

Will Glaxo (GSK) Beat Earnings Estimates This Season? - Analyst Blog

Will Isis Pharmaceuticals (ISIS) Disappoint in Q1 Earnings? - Analyst Blog

GlaxoSmithKline And Theravance: The Asthma Approval In Figures

Tumor profiling goes public: HTG Molecular Diagnostics sets terms for $50 million IPO

Today's Top Performers In Drugs

If You Live in This State, You May Lose the Choice Whether to Vaccinate Your Kids

California could mandate that children be vaccinated if they want to attend public school.

See More GSK News...

GSK's Top Competitors

GSK $45.60 (-1.60%)
Current stock: GSK
JNJ $99.50 (-0.85%)
Current stock: JNJ
NVS $102.17 (-1.39%)
Current stock: NVS
RHHBY $35.90 (-0.42%)
Current stock: RHHBY